Identification of prognostic genes in the acute myeloid leukemia microenvironment

• Published in: Aging (Albany, NY.) Vol. 11; no. 22; pp. 10557 - 10580
• Main Authors: Huang, Shaoxin, Zhang, Biyu, Fan, Wenyan, Zhao, Qihan, Yang, Lei, Xin, Wang, Fu, Denggang
• Format: Journal Article
• Language: English
• Published: United States Impact Journals 18.11.2019
• Subjects: Research Paper; microenvironment; overall survival; immune scores; acute myeloid leukemia; stromal scores
• ISSN: 1945-4589; 1945-4589
• DOI: 10.18632/aging.102477

The tumor microenvironment (TME) has a strong influence on the progression, therapeutic response, and clinical outcome of acute myeloid leukemia (AML), one of the most common hematopoietic malignancies in adults. In this study, we identified TME-related genes associated with AML prognosis. Gene expression profiles from AML patients were downloaded from TCGA database, and immune and stromal scores were calculated using the ESTIMATE algorithm. Immune scores were correlated with clinical features such as FAB subtypes and patient's age. After categorizing AML cases into high and low score groups, an association between several differentially expressed genes (DEGs) and overall survival was identified. Functional enrichment analysis of the DEGs showed that they were primarily enriched in the immune response, inflammatory response, and cytokine activity, and were involved in signaling processes related to hematopoietic cell lineage, B cell receptor, and chemokine pathways. Two significant modules, dominated respectively by CCR5 and ITGAM nodes, were identified from the PPI network, and 20 hub genes were extracted. A total of 112 DEGs correlated with poor overall survival of AML patients, and 11 of those genes were validated in a separate TARGET-AML cohort. By identifying TME-associated genes, our findings may lead to improved prognoses and therapies for AML.